journal article·2021-01-06

Linking Aggregation in Solution, Solvation, and Solubility of Simvastatin: An Experimental and MD Simulation Study

Ricardo G. Simões, Pedro L. T. Melo, Carlos E. S. Bernardes, Maria T. Heilmann, Franziska Emmerling, Manuel E. Minas da Piedade

Crystal Growth & Design· Volume 21· Issue 1
Publisher page

Abstract

The solubility is generally thought to be higher if the solvent effectively solvates solute molecules that are well-separated from each other. The present work suggests, however, that the formation of large solute aggregates does not necessarily imply less effective solvation and lower solubility. Measurements of the solubility of simvastatin (one of the most commonly prescribed antihyperlipidemic drugs) in three solvents with different polarities and protic characters, led to the solubility order acetone > ethyl acetate > ethanol, in the full temperature range covered by the experiments (283–308 K). An analysis of the structures of the different solutions on the basis of molecular dynamics simulation results indicated that this trend seems to be determined by a balance between the solute tendency toward aggregation and the ability of the solvent to efficiently solvate it, by integrating the cluster structures, regardless of their size, and effectively establishing solvent–solute interactions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallization and Solubility Studies · Pharmacological Effects of Natural Compounds · Computational Drug Discovery Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centro de Química Estrutural, Faculdade de Ciências Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal

BAM Federal Institute for Materials Research and Testing, Richard-Willstaetter-Strasse 11, 12489 Berlin, Germany

Humboldt-Universität zu Berlin, Department of Chemistry, Brook-Taylor Strasse 2, D-12489 Berlin, Germany

Funding

Deutscher Akademischer Austauschdienst · European Regional Development Fund · Funda??o para a Ci?ncia e a Tecnologia

References (35)

Show source-provided references
1. 10.1016/j.molstruc.2013.11.05010.1016/j.molstruc.2013.11.050 ↗
2. 10.1002/chem.1997003061010.1002/chem.19970030610 ↗
3. 10.1021/jp710658210.1021/jp7106582 ↗
4. 10.1039/b418603f10.1039/b418603f ↗
5. 10.1021/cg060058a10.1021/cg060058a ↗
6. 10.1021/cg500441g10.1021/cg500441g ↗
7. 10.1021/cg000009c10.1021/cg000009c ↗
8. 10.1039/b407163h10.1039/b407163h ↗
9. 10.1021/jp055982e10.1021/jp055982e ↗
10. 10.1021/acs.jpca.8b0134210.1021/acs.jpca.8b01342 ↗
11. 10.1039/C8CE02108B10.1039/C8CE02108B ↗
12. 10.1021/jp103099j10.1021/jp103099j ↗
13. 2019
14. Li, J. J. Triumph of the Heart. The Story of Statins; Oxford University Press: New York, 2009; 28–30.10.1093/oso/9780195323573.003.0008 ↗
15. 10.1021/mp400132r10.1021/mp400132r ↗
16. 10.1021/acs.molpharmaceut.8b0081810.1021/acs.molpharmaceut.8b00818 ↗
17. 10.1107/S010827010301251410.1107/S0108270103012514 ↗
18. 10.1007/s11224-009-9579-910.1007/s11224-009-9579-9 ↗
19. Bernstein, J. Polymorphism in Molecular Crystals, 2nd ed. Oxford University Press: Oxford, 2020; pp 69–72.10.1093/oso/9780199655441.001.0001 ↗
20. 10.1016/j.molstruc.2011.03.04810.1016/j.molstruc.2011.03.048 ↗
21. 10.1016/j.fluid.2009.03.00610.1016/j.fluid.2009.03.006 ↗
22. 10.1016/j.fluid.2015.07.05510.1016/j.fluid.2015.07.055 ↗
23. 10.1016/j.jct.2011.11.02310.1016/j.jct.2011.11.023 ↗
24. Haynes W. M. · 2017
25. 10.1515/pac-2015-030510.1515/pac-2015-0305 ↗
26. 10.1016/j.softx.2015.06.00110.1016/j.softx.2015.06.001 ↗
27. 10.1021/ja962176010.1021/ja9621760 ↗
28. 10.1021/jp962425710.1021/jp9624257 ↗
29. 10.1021/jp512349r10.1021/jp512349r ↗
30. 10.1002/jcc.2122410.1002/jcc.21224 ↗
31. 10.1002/jcc.2473510.1002/jcc.24735 ↗
32. 10.1021/j100785a00110.1021/j100785a001 ↗
33. Atkins P. W. · 2018
34. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
35. Prausnitz J. M. · 1999